APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amifostine

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.

Selected research

Market Analysis & Forecast

Global Amifostine Market Analysis and Forecast 2026-2032

9 January 2026197 pages

Choose your research edition.

Industry ResearchAmifostine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Amifostine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Amifostine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amifostine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Amifostine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.

Global Amifostine key players include Sun Pharmaceutical, Clinigen Group, Merro Pharmaceutical, Taj Pharmaceuticals, Luye Pharma, etc. Global top five manufacturers hold a share over 90%. North America is the largest sales market, with a share over 50%, followed by Asia-Pacific with a share over 40 percent.

This report presents an overview of global market for Amifostine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Amifostine, also provides the sales of main regions and countries. Of the upcoming market potential for Amifostine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Amifostine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Amifostine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Amifostine sales, projected growth trends, production technology, application and end-user industry.

Amifostine Segment by Company

Clinigen

Sun Pharmaceutical

Taj Pharmaceuticals

Merro Pharmaceutical

Luye Pharma

Mingren Pharma

Amifostine Segment by Type

400mg/Dose

500mg/Dose

Amifostine Segment by Application

Head and Neck Cancer Adjuvant Therapy

Others

Amifostine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amifostine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amifostine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amifostine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Amifostine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Amifostine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amifostine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Amifostine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 400mg/Dose Major Manufacturers Table 3. 500mg/Dose Major Manufacturers Table 4. Global Amifostine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Head and Neck Cancer Adjuvant Therapy Major Manufacturers Table 6. Others Major Manufacturers Table 7. Amifostine Industry Trends Table 8. Amifostine Industry Drivers Table 9. Amifostine Industry Opportunities and Challenges Table 10. Amifostine Industry Restraints Table 11. Global Amifostine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Amifostine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Amifostine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Amifostine Revenue Market Share by Region (2021-2026) Table 15. Global Amifostine Revenue Market Share by Region (2027-2032) Table 16. Global Amifostine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Amifostine Sales by Region (2021-2026) & (K Units) Table 18. Global Amifostine Sales by Region (2027-2032) & (K Units) Table 19. Global Amifostine Sales Market Share by Region (2021-2026) Table 20. Global Amifostine Sales Market Share by Region (2027-2032) Table 21. Global Amifostine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Amifostine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Amifostine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Amifostine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Amifostine Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 26. Global Amifostine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Amifostine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Amifostine Manufacturers, Product Type & Application Table 29. Global Amifostine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Amifostine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Amifostine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Amifostine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Amifostine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Amifostine Revenue Market Share by Type (2021-2026) Table 36. Global Amifostine Revenue Market Share by Type (2027-2032) Table 37. Global Amifostine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Amifostine Sales by Type (2021-2026) & (K Units) Table 39. Global Amifostine Sales by Type (2027-2032) & (K Units) Table 40. Global Amifostine Sales Market Share by Type (2021-2026) Table 41. Global Amifostine Sales Market Share by Type (2027-2032) Table 42. Global Amifostine Price by Type (2021-2026) & (USD/Unit) Table 43. Global Amifostine Price by Type (2027-2032) & (USD/Unit) Table 44. Global Amifostine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Amifostine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Amifostine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Amifostine Revenue Market Share by Application (2021-2026) Table 48. Global Amifostine Revenue Market Share by Application (2027-2032) Table 49. Global Amifostine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Amifostine Sales by Application (2021-2026) & (K Units) Table 51. Global Amifostine Sales by Application (2027-2032) & (K Units) Table 52. Global Amifostine Sales Market Share by Application (2021-2026) Table 53. Global Amifostine Sales Market Share by Application (2027-2032) Table 54. Global Amifostine Price by Application (2021-2026) & (USD/Unit) Table 55. Global Amifostine Price by Application (2027-2032) & (USD/Unit) Table 56. Clinigen Company Information Table 57. Clinigen Business Overview Table 58. Clinigen Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 59. Clinigen Amifostine Product Portfolio Table 60. Clinigen Recent Development Table 61. Sun Pharmaceutical Company Information Table 62. Sun Pharmaceutical Business Overview Table 63. Sun Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 64. Sun Pharmaceutical Amifostine Product Portfolio Table 65. Sun Pharmaceutical Recent Development Table 66. Taj Pharmaceuticals Company Information Table 67. Taj Pharmaceuticals Business Overview Table 68. Taj Pharmaceuticals Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 69. Taj Pharmaceuticals Amifostine Product Portfolio Table 70. Taj Pharmaceuticals Recent Development Table 71. Merro Pharmaceutical Company Information Table 72. Merro Pharmaceutical Business Overview Table 73. Merro Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Merro Pharmaceutical Amifostine Product Portfolio Table 75. Merro Pharmaceutical Recent Development Table 76. Luye Pharma Company Information Table 77. Luye Pharma Business Overview Table 78. Luye Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Luye Pharma Amifostine Product Portfolio Table 80. Luye Pharma Recent Development Table 81. Mingren Pharma Company Information Table 82. Mingren Pharma Business Overview Table 83. Mingren Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Mingren Pharma Amifostine Product Portfolio Table 85. Mingren Pharma Recent Development Table 86. North America Amifostine Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Amifostine Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Amifostine Sales by Type (2021-2026) & (K Units) Table 89. North America Amifostine Sales by Type (2027-2032) & (K Units) Table 90. North America Amifostine Sales Price by Type (2021-2026) & (USD/Unit) Table 91. North America Amifostine Sales Price by Type (2027-2032) & (USD/Unit) Table 92. North America Amifostine Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Amifostine Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Amifostine Sales by Application (2021-2026) & (K Units) Table 95. North America Amifostine Sales by Application (2027-2032) & (K Units) Table 96. North America Amifostine Sales Price by Application (2021-2026) & (USD/Unit) Table 97. North America Amifostine Sales Price by Application (2027-2032) & (USD/Unit) Table 98. North America Amifostine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Amifostine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. North America Amifostine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. North America Amifostine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 102. North America Amifostine Sales by Country (2021-2026) & (K Units) Table 103. North America Amifostine Sales by Country (2027-2032) & (K Units) Table 104. North America Amifostine Sales Price by Country (2021-2026) & (USD/Unit) Table 105. North America Amifostine Sales Price by Country (2027-2032) & (USD/Unit) Table 106. United States Amifostine Revenue (2021-2032) & (US$ Million) Table 107. Canada Amifostine Revenue (2021-2032) & (US$ Million) Table 108. Mexico Amifostine Revenue (2021-2032) & (US$ Million) Table 109. Europe Amifostine Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Amifostine Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Amifostine Sales by Type (2021-2026) & (K Units) Table 112. Europe Amifostine Sales by Type (2027-2032) & (K Units) Table 113. Europe Amifostine Sales Price by Type (2021-2026) & (USD/Unit) Table 114. Europe Amifostine Sales Price by Type (2027-2032) & (USD/Unit) Table 115. Europe Amifostine Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Amifostine Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Amifostine Sales by Application (2021-2026) & (K Units) Table 118. Europe Amifostine Sales by Application (2027-2032) & (K Units) Table 119. Europe Amifostine Sales Price by Application (2021-2026) & (USD/Unit) Table 120. Europe Amifostine Sales Price by Application (2027-2032) & (USD/Unit) Table 121. Europe Amifostine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Amifostine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Amifostine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Amifostine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. Europe Amifostine Sales by Country (2021-2026) & (K Units) Table 126. Europe Amifostine Sales by Country (2027-2032) & (K Units) Table 127. Europe Amifostine Sales Price by Country (2021-2026) & (USD/Unit) Table 128. Europe Amifostine Sales Price by Country (2027-2032) & (USD/Unit) Table 129. Germany Amifostine Revenue (2021-2032) & (US$ Million) Table 130. France Amifostine Revenue (2021-2032) & (US$ Million) Table 131. U.K. Amifostine Revenue (2021-2032) & (US$ Million) Table 132. Italy Amifostine Revenue (2021-2032) & (US$ Million) Table 133. Russia Amifostine Revenue (2021-2032) & (US$ Million) Table 134. Spain Amifostine Revenue (2021-2032) & (US$ Million) Table 135. Netherlands Amifostine Revenue (2021-2032) & (US$ Million) Table 136. Switzerland Amifostine Revenue (2021-2032) & (US$ Million) Table 137. Sweden Amifostine Revenue (2021-2032) & (US$ Million) Table 138. Poland Amifostine Revenue (2021-2032) & (US$ Million) Table 139. China Amifostine Revenue by Type (2021-2026) & (US$ Million) Table 140. China Amifostine Revenue by Type (2027-2032) & (US$ Million) Table 141. China Amifostine Sales by Type (2021-2026) & (K Units) Table 142. China Amifostine Sales by Type (2027-2032) & (K Units) Table 143. China Amifostine Sales Price by Type (2021-2026) & (USD/Unit) Table 144. China Amifostine Sales Price by Type (2027-2032) & (USD/Unit) Table 145. China Amifostine Revenue by Application (2021-2026) & (US$ Million) Table 146. China Amifostine Revenue by Application (2027-2032) & (US$ Million) Table 147. China Amifostine Sales by Application (2021-2026) & (K Units) Table 148. China Amifostine Sales by Application (2027-2032) & (K Units) Table 149. China Amifostine Sales Price by Application (2021-2026) & (USD/Unit) Table 150. China Amifostine Sales Price by Application (2027-2032) & (USD/Unit) Table 151. Asia Amifostine Revenue by Type (2021-2026) & (US$ Million) Table 152. Asia Amifostine Revenue by Type (2027-2032) & (US$ Million) Table 153. Asia Amifostine Sales by Type (2021-2026) & (K Units) Table 154. Asia Amifostine Sales by Type (2027-2032) & (K Units) Table 155. Asia Amifostine Sales Price by Type (2021-2026) & (USD/Unit) Table 156. Asia Amifostine Sales Price by Type (2027-2032) & (USD/Unit) Table 157. Asia Amifostine Revenue by Application (2021-2026) & (US$ Million) Table 158. Asia Amifostine Revenue by Application (2027-2032) & (US$ Million) Table 159. Asia Amifostine Sales by Application (2021-2026) & (K Units) Table 160. Asia Amifostine Sales by Application (2027-2032) & (K Units) Table 161. Asia Amifostine Sales Price by Application (2021-2026) & (USD/Unit) Table 162. Asia Amifostine Sales Price by Application (2027-2032) & (USD/Unit) Table 163. Asia Amifostine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Asia Amifostine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. Asia Amifostine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. Asia Amifostine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 167. Asia Amifostine Sales by Country (2021-2026) & (K Units) Table 168. Asia Amifostine Sales by Country (2027-2032) & (K Units) Table 169. Asia Amifostine Sales Price by Country (2021-2026) & (USD/Unit) Table 170. Asia Amifostine Sales Price by Country (2027-2032) & (USD/Unit) Table 171. Japan Amifostine Revenue (2021-2032) & (US$ Million) Table 172. South Korea Amifostine Revenue (2021-2032) & (US$ Million) Table 173. India Amifostine Revenue (2021-2032) & (US$ Million) Table 174. Australia Amifostine Revenue (2021-2032) & (US$ Million) Table 175. Taiwan Amifostine Revenue (2021-2032) & (US$ Million) Table 176. Southeast Asia Amifostine Revenue (2021-2032) & (US$ Million) Table 177. SAMEA Amifostine Revenue by Type (2021-2026) & (US$ Million) Table 178. SAMEA Amifostine Revenue by Type (2027-2032) & (US$ Million) Table 179. SAMEA Amifostine Sales by Type (2021-2026) & (K Units) Table 180. SAMEA Amifostine Sales by Type (2027-2032) & (K Units) Table 181. SAMEA Amifostine Sales Price by Type (2021-2026) & (USD/Unit) Table 182. SAMEA Amifostine Sales Price by Type (2027-2032) & (USD/Unit) Table 183. SAMEA Amifostine Revenue by Application (2021-2026) & (US$ Million) Table 184. SAMEA Amifostine Revenue by Application (2027-2032) & (US$ Million) Table 185. SAMEA Amifostine Sales by Application (2021-2026) & (K Units) Table 186. SAMEA Amifostine Sales by Application (2027-2032) & (K Units) Table 187. SAMEA Amifostine Sales Price by Application (2021-2026) & (USD/Unit) Table 188. SAMEA Amifostine Sales Price by Application (2027-2032) & (USD/Unit) Table 189. SAMEA Amifostine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. SAMEA Amifostine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. SAMEA Amifostine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. SAMEA Amifostine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 193. SAMEA Amifostine Sales by Country (2021-2026) & (K Units) Table 194. SAMEA Amifostine Sales by Country (2027-2032) & (K Units) Table 195. SAMEA Amifostine Sales Price by Country (2021-2026) & (USD/Unit) Table 196. SAMEA Amifostine Sales Price by Country (2027-2032) & (USD/Unit) Table 197. Brazil Amifostine Revenue (2021-2032) & (US$ Million) Table 198. Argentina Amifostine Revenue (2021-2032) & (US$ Million) Table 199. Chile Amifostine Revenue (2021-2032) & (US$ Million) Table 200. Colombia Amifostine Revenue (2021-2032) & (US$ Million) Table 201. Peru Amifostine Revenue (2021-2032) & (US$ Million) Table 202. Saudi Arabia Amifostine Revenue (2021-2032) & (US$ Million) Table 203. Israel Amifostine Revenue (2021-2032) & (US$ Million) Table 204. UAE Amifostine Revenue (2021-2032) & (US$ Million) Table 205. Turkey Amifostine Revenue (2021-2032) & (US$ Million) Table 206. Iran Amifostine Revenue (2021-2032) & (US$ Million) Table 207. Egypt Amifostine Revenue (2021-2032) & (US$ Million) Table 208. Key Raw Materials Table 209. Raw Materials Key Suppliers Table 210. Amifostine Distributors List Table 211. Amifostine Customers List Table 212. Research Programs/Design for This Report Table 213. Authors List of This Report Table 214. Secondary Sources Table 215. Primary Sources List of Figures Figure 1. Amifostine Image Figure 2. Global Amifostine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amifostine Market Size Share 2021 VS 2025 VS 2032 Figure 4. 400mg/Dose Image Figure 5. 500mg/Dose Image Figure 6. Global Amifostine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Amifostine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Head and Neck Cancer Adjuvant Therapy Image Figure 9. Others Image Figure 10. Global Amifostine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Amifostine Revenue (2021-2032) & (US$ Million) Figure 12. Global Amifostine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Amifostine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Amifostine Revenue Market Share by Region (2021-2032) Figure 15. Global Amifostine Sales (2021-2032) & (K Units) Figure 16. Global Amifostine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Amifostine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Amifostine Sales YoY (2021-2032) & (K Units) Figure 19. Europe Amifostine Sales YoY (2021-2032) & (K Units) Figure 20. China Amifostine Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Amifostine Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Amifostine Sales YoY (2021-2032) & (K Units) Figure 23. Global Amifostine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Amifostine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Amifostine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Amifostine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Amifostine Revenue Market Share by Type (2021-2032) Figure 29. Global Amifostine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Amifostine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Amifostine Sales Market Share by Type (2021-2032) Figure 32. Global Amifostine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Amifostine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Amifostine Revenue Market Share by Application (2021-2032) Figure 35. Global Amifostine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Amifostine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Amifostine Sales Market Share by Application (2021-2032) Figure 38. North America Amifostine Revenue Share by Type (2021-2032) Figure 39. North America Amifostine Sales Share by Type (2021-2032) Figure 40. North America Amifostine Revenue Share by Application (2021-2032) Figure 41. North America Amifostine Sales Share by Application (2021-2032) Figure 42. North America Amifostine Revenue Share by Country (2021-2032) Figure 43. North America Amifostine Sales Share by Country (2021-2032) Figure 44. Europe Amifostine Revenue Share by Type (2021-2032) Figure 45. Europe Amifostine Sales Share by Type (2021-2032) Figure 46. Europe Amifostine Revenue Share by Application (2021-2032) Figure 47. Europe Amifostine Sales Share by Application (2021-2032) Figure 48. Europe Amifostine Revenue Share by Country (2021-2032) Figure 49. Europe Amifostine Sales Share by Country (2021-2032) Figure 50. China Amifostine Revenue Share by Type (2021-2032) Figure 51. China Amifostine Sales Share by Type (2021-2032) Figure 52. China Amifostine Revenue Share by Application (2021-2032) Figure 53. China Amifostine Sales Share by Application (2021-2032) Figure 54. Asia Amifostine Revenue Share by Type (2021-2032) Figure 55. Asia Amifostine Sales Share by Type (2021-2032) Figure 56. Asia Amifostine Revenue Share by Application (2021-2032) Figure 57. Asia Amifostine Sales Share by Application (2021-2032) Figure 58. Asia Amifostine Revenue Share by Country (2021-2032) Figure 59. Asia Amifostine Sales Share by Country (2021-2032) Figure 60. SAMEA Amifostine Revenue Share by Type (2021-2032) Figure 61. SAMEA Amifostine Sales Share by Type (2021-2032) Figure 62. SAMEA Amifostine Revenue Share by Application (2021-2032) Figure 63. SAMEA Amifostine Sales Share by Application (2021-2032) Figure 64. SAMEA Amifostine Revenue Share by Country (2021-2032) Figure 65. SAMEA Amifostine Sales Share by Country (2021-2032) Figure 66. Amifostine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Amifostine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 400mg/Dose
  • 500mg/Dose
Applications
  • Head and Neck Cancer Adjuvant Therapy
  • Others
Companies covered
  • Clinigen
  • Sun Pharmaceutical
  • Taj Pharmaceuticals
  • Merro Pharmaceutical
  • Luye Pharma
  • Mingren Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Amifostine Market by Type
  3. 1.2.1 Global Amifostine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 400mg/Dose
  5. 1.2.3 500mg/Dose
  6. 1.3 Amifostine Market by Application
  7. 1.3.1 Global Amifostine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Head and Neck Cancer Adjuvant Therapy
  9. 1.3.3 Others
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Amifostine Market Dynamics
  1. 2.1 Amifostine Industry Trends
  2. 2.2 Amifostine Industry Drivers
  3. 2.3 Amifostine Industry Opportunities and Challenges
  4. 2.4 Amifostine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Amifostine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Amifostine Revenue by Region
  3. 3.2.1 Global Amifostine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Amifostine Revenue by Region (2021-2026)
  5. 3.2.3 Global Amifostine Revenue by Region (2027-2032)
  6. 3.2.4 Global Amifostine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Amifostine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Amifostine Sales by Region
  9. 3.4.1 Global Amifostine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Amifostine Sales by Region (2021-2026)
  11. 3.4.3 Global Amifostine Sales by Region (2027-2032)
  12. 3.4.4 Global Amifostine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Amifostine Revenue by Manufacturers
  2. 4.1.1 Global Amifostine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Amifostine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Amifostine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Amifostine Sales by Manufacturers
  6. 4.2.1 Global Amifostine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Amifostine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Amifostine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Amifostine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Amifostine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Amifostine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Amifostine Manufacturers, Product Type & Application
  13. 4.7 Global Amifostine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Amifostine Market CR5 and HHI
  16. 4.8.2 2025 Amifostine Tier 1, Tier 2, and Tier 3
5 Amifostine Market by Type
  1. 5.1 Global Amifostine Revenue by Type
  2. 5.1.1 Global Amifostine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Amifostine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Amifostine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Amifostine Sales by Type
  6. 5.2.1 Global Amifostine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Amifostine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Amifostine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Amifostine Price by Type
6 Amifostine Market by Application
  1. 6.1 Global Amifostine Revenue by Application
  2. 6.1.1 Global Amifostine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Amifostine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Amifostine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Amifostine Sales by Application
  6. 6.2.1 Global Amifostine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Amifostine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Amifostine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Amifostine Price by Application
7 Company Profiles
  1. 7.1 Clinigen
  2. 7.1.1 Clinigen Company Information
  3. 7.1.2 Clinigen Business Overview
  4. 7.1.3 Clinigen Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Clinigen Amifostine Product Portfolio
  6. 7.1.5 Clinigen Recent Developments
  7. 7.2 Sun Pharmaceutical
  8. 7.2.1 Sun Pharmaceutical Company Information
  9. 7.2.2 Sun Pharmaceutical Business Overview
  10. 7.2.3 Sun Pharmaceutical Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sun Pharmaceutical Amifostine Product Portfolio
  12. 7.2.5 Sun Pharmaceutical Recent Developments
  13. 7.3 Taj Pharmaceuticals
  14. 7.3.1 Taj Pharmaceuticals Company Information
  15. 7.3.2 Taj Pharmaceuticals Business Overview
  16. 7.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Taj Pharmaceuticals Amifostine Product Portfolio
  18. 7.3.5 Taj Pharmaceuticals Recent Developments
  19. 7.4 Merro Pharmaceutical
  20. 7.4.1 Merro Pharmaceutical Company Information
  21. 7.4.2 Merro Pharmaceutical Business Overview
  22. 7.4.3 Merro Pharmaceutical Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merro Pharmaceutical Amifostine Product Portfolio
  24. 7.4.5 Merro Pharmaceutical Recent Developments
  25. 7.5 Luye Pharma
  26. 7.5.1 Luye Pharma Company Information
  27. 7.5.2 Luye Pharma Business Overview
  28. 7.5.3 Luye Pharma Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Luye Pharma Amifostine Product Portfolio
  30. 7.5.5 Luye Pharma Recent Developments
  31. 7.6 Mingren Pharma
  32. 7.6.1 Mingren Pharma Company Information
  33. 7.6.2 Mingren Pharma Business Overview
  34. 7.6.3 Mingren Pharma Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Mingren Pharma Amifostine Product Portfolio
  36. 7.6.5 Mingren Pharma Recent Developments
8 North America
  1. 8.1 North America Amifostine Market Size by Type
  2. 8.1.1 North America Amifostine Revenue by Type (2021-2032)
  3. 8.1.2 North America Amifostine Sales by Type (2021-2032)
  4. 8.1.3 North America Amifostine Price by Type (2021-2032)
  5. 8.2 North America Amifostine Market Size by Application
  6. 8.2.1 North America Amifostine Revenue by Application (2021-2032)
  7. 8.2.2 North America Amifostine Sales by Application (2021-2032)
  8. 8.2.3 North America Amifostine Price by Application (2021-2032)
  9. 8.3 North America Amifostine Market Size by Country
  10. 8.3.1 North America Amifostine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Amifostine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Amifostine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Amifostine Market Size by Type
  2. 9.1.1 Europe Amifostine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Amifostine Sales by Type (2021-2032)
  4. 9.1.3 Europe Amifostine Price by Type (2021-2032)
  5. 9.2 Europe Amifostine Market Size by Application
  6. 9.2.1 Europe Amifostine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Amifostine Sales by Application (2021-2032)
  8. 9.2.3 Europe Amifostine Price by Application (2021-2032)
  9. 9.3 Europe Amifostine Market Size by Country
  10. 9.3.1 Europe Amifostine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Amifostine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Amifostine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Amifostine Market Size by Type
  2. 10.1.1 China Amifostine Revenue by Type (2021-2032)
  3. 10.1.2 China Amifostine Sales by Type (2021-2032)
  4. 10.1.3 China Amifostine Price by Type (2021-2032)
  5. 10.2 China Amifostine Market Size by Application
  6. 10.2.1 China Amifostine Revenue by Application (2021-2032)
  7. 10.2.2 China Amifostine Sales by Application (2021-2032)
  8. 10.2.3 China Amifostine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Amifostine Market Size by Type
  2. 11.1.1 Asia Amifostine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Amifostine Sales by Type (2021-2032)
  4. 11.1.3 Asia Amifostine Price by Type (2021-2032)
  5. 11.2 Asia Amifostine Market Size by Application
  6. 11.2.1 Asia Amifostine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Amifostine Sales by Application (2021-2032)
  8. 11.2.3 Asia Amifostine Price by Application (2021-2032)
  9. 11.3 Asia Amifostine Market Size by Country
  10. 11.3.1 Asia Amifostine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Amifostine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Amifostine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Amifostine Market Size by Type
  2. 12.1.1 SAMEA Amifostine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Amifostine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Amifostine Price by Type (2021-2032)
  5. 12.2 SAMEA Amifostine Market Size by Application
  6. 12.2.1 SAMEA Amifostine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Amifostine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Amifostine Price by Application (2021-2032)
  9. 12.3 SAMEA Amifostine Market Size by Country
  10. 12.3.1 SAMEA Amifostine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Amifostine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Amifostine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Amifostine Value Chain Analysis
  2. 13.1.1 Amifostine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Amifostine Production Mode & Process
  6. 13.2 Amifostine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Amifostine Distributors
  9. 13.2.3 Amifostine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst